$1250 | Single User
$1800 | Site License
$2500 | Global License

Cystic Fibrosis Deals Activity Report, 2010-2020
[Lowest Price Guaranteed: $1,250]

Published by Gervano R A: 29 Mar 2019 | 270549 | In Stock
Related Topics: Cystic Fibrosis

Introduction

GervanoRA's ‘Cystic Fibrosis Deals Activity Report, 2010-2020’ has analyzed and provided an understanding of the overall competition in partnering landscape in the disease area that has occurred from the year 2010.

GervanoRA has analyzed more than 90 drug candidates in the current development pipeline. Hence, a number of emerging and clinical-stage companies are embarking with collaborations or partnerships with different pharma companies to aid in the development process of their respective drug candidates. In the light of rocketing competition, not only companies, but also universities, institutes and research centers are getting actively involved in the advancements of new medicines for the treatment of the disease.

The report through its meticulous analysis on global therapeutic landscape of Cystic Fibrosis deals assists companies in taking future partnering decisions based on competitor's R&D activities; current trends in partnering landscape in order to avoid or mitigate competitive market risks.

For a proper understanding, GervanoRA has segmented the report into sections based on:

Analytics based on deal type,

Analytics based on deal by value,

Analytics based on geography

Analytics based on deal maker

Year-by-year analytics

The report also includes case studies provided for the deals that were prominent and unique among all the deals.

Table of Contents
for Cystic Fibrosis Deals Activity Report, 2010-2020

  • TABLE OF CONTENTS

    1. INTRODUCTION

    1.1. REPORT DESCRIPTION

    1.2. METHODOLOGY

    1.3. OTHER AVAILABLE DEALS ANALYSIS REPORTS

    1.4. ABOUT US: GERVANORA DATA SERVICES

    2. EXECUTIVE SUMMARY

    3. ANALYTICS BY DEAL TYPE

    3.1. CYSTIC FIBROSIS AGREEMENTS

    3.2. CYSTIC FIBROSIS COLLABORATIONS

    3.3. CYSTIC FIBROSIS MERGERS & ACQUISITIONS

    3.4. CYSTIC FIBROSIS FINANCING- GRANT AND FUNDING DEALS

    3.5. CYSTIC FIBROSIS LICENSING DEALS

    3.6. CYSTIC FIBROSIS ALLIANCE DEAL

    4. ANALYTICS BY DEAL VALUE AND GEOGRAPHY

    5. ANALYTICS BY ACTIVE PLAYERS

    6. ANALYTICS BY ANNUAL FREQUENCY

    7. CASE STUDIES- TOP FIVE PROMINENT DEALS

    DEAL 1: ROYALTY PHARMA ANNOUNCES .3 BN ROYALTY TRANSACTION WITH CYSTIC FIBROSIS FOUNDATION THERAPEUTICS

    DEAL 2: ASTRAZENECA TO SELL SMALL MOLECULE ANTIBIOTICS BUSINESS TO PFIZER

    DEAL 3: VERTEX AND PARION SCIENCES ESTABLISH COLLABORATION TO DEVELOP EPITHELIAL SODIUM CHANNEL (ENAC) INHIBITORS IN CYSTIC FIBROSIS AND OTHER PULMONARY DISEASES

    DEAL 4: VERTEX AND MODERNA ESTABLISH EXCLUSIVE COLLABORATION TO DISCOVER AND DEVELOP MRNA THERAPEUTICS FOR CYSTIC FIBROSIS

    DEAL 5: VERTEX AND CRISPR THERAPEUTICS ESTABLISH COLLABORATION TO USE CRISPR-CAS9 GENE EDITING TECHNOLOGY TO DISCOVER AND DEVELOP NEW TREATMENTS FOR GENETIC DISEASES

    8. ABBREVIATIONS

List Of Tables
in Cystic Fibrosis Deals Activity Report, 2010-2020

LIST OF TABLES

TABLE 01: MAJOR AGREEMENTS IN THE CYSTIC FIBROSIS AREA

TABLE 02: MAJOR COLLABORATIONS IN THE CYSTIC FIBROSIS AREA

TABLE 03: MAJOR COLLABORATIONS IN THE CYSTIC FIBROSIS AREA

TABLE 04: MAJOR FINANCING DEALS- GRANTS AND FUNDING IN THE CYSTIC FIBROSIS AREA

TABLE 05: MAJOR LICENSING DEALS IN THE CYSTIC FIBROSIS AREA

TABLE 06: TOP 10 MAJOR DEALS IN THE CYSTIC FIBROSIS AREA RANKED BY DEAL AMOUNT

List Of Figures, Charts and Diagrams
in Cystic Fibrosis Deals Activity Report, 2010-2020

LIST OF FIGURES

FIGURE 01: CYSTIC FIBROSIS DEALS, BY DEAL TYPE

FIGURE 02: CYSTIC FIBROSIS DEAL AMOUNT SHARE BY DEAL TYPE

FIGURE 03: CYCTIC FIBROSIS DEALS SCENARIO, YEAR V/S DEAL AMOUNT

FIGURE 04: PHARMACEUTICAL COMPANIES INVOLVED IN MORE THAN A SINGLE DEAL IN CF AREA

FIGURE 05: NUMBER OF CYSTIC FIBROSIS DEALS, YEAR BY YEAR

FIGURE 06: INCREASING AGREEMENT DEALS

Additional Details

Publisher

Gervano R A

Publisher Information

GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports, and consulting services, based in Goa. It provides Market Research And Analysis Services to its clients globally.



GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends.



At GervanoRA Data Services, we’re playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations to garner valuable key insights.

Reference

270549 | GERPD001

Number of Pages

41

Report Format

PDF

Gervano R A Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Cystic Fibrosis Foundation Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCystic Fibrosis Foundation Therapeutics Inc (Cystic) is a healthcare organization that develo...
25 Nov 2016 by Global Data USD $250 More Info
Global Cystic Fibrosis Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Cystic Fibrosis Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Cystic Fibrosis Global Clinical Trials Review, H2, 2016
Cystic Fibrosis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “C...
31 Aug 2016 by Global Data USD $2,500 More Info
Cystic Fibrosis Global Clinical Trials Review, H2, 2016
Cystic Fibrosis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “C...
31 Aug 2016 by Global Data USD $2,500 More Info
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of...
01 Aug 2016 by GBI Research USD $4,995 More Info
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of...
01 Aug 2016 by GBI Research USD $4,995 More Info
Cystic Fibrosis Foundation Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCystic Fibrosis Foundation Therapeutics, Inc. (Cystic) is a healthcare organization which dev...
06 May 2016 by Global Data USD $250 More Info
Cystic Fibrosis Foundation Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $350 More Info
Cystic Fibrosis Foundation Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryCystic Fibrosis Foundation Therapeutics, Inc. (Cystic) is a healthcare organization which dev...
09 Mar 2016 by Global Data USD $250 More Info

This report is published by Gervano R A

GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports, and consulting services, based in Goa. It provides Market Research And Analysis Services to its clients globally.

GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends.

At GervanoRA Data Services, we’re playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations to garner valuable key insights.

Download Free Report Summary PDF

Cystic Fibrosis Deals Activity Report, 2010-2020 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...